BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32200655)

  • 1. Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen.
    Deplano A; Karlsson J; Svensson M; Moraca F; Catalanotti B; Fowler CJ; Onnis V
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):815-823. PubMed ID: 32200655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and
    Deplano A; Karlsson J; Moraca F; Svensson M; Cristiano C; Morgillo CM; Fowler CJ; Russo R; Catalanotti B; Onnis V
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):940-953. PubMed ID: 33896320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide.
    Fowler CJ; Björklund E; Lichtman AH; Naidu PS; Congiu C; Onnis V
    J Enzyme Inhib Med Chem; 2013 Feb; 28(1):172-82. PubMed ID: 22225576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors.
    Deplano A; Cipriano M; Moraca F; Novellino E; Catalanotti B; Fowler CJ; Onnis V
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):562-576. PubMed ID: 30688118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
    Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ
    Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.
    Cipriano M; Björklund E; Wilson AA; Congiu C; Onnis V; Fowler CJ
    Eur J Pharmacol; 2013 Nov; 720(1-3):383-90. PubMed ID: 24120370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor.
    Gouveia-Figueira S; Karlsson J; Deplano A; Hashemian S; Svensson M; Fredriksson Sundbom M; Congiu C; Onnis V; Fowler CJ
    PLoS One; 2015; 10(9):e0139212. PubMed ID: 26406890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fatty acid amide hydrolase and cyclooxygenase-inhibitory properties of novel amide derivatives of carprofen.
    Deplano A; Karlsson J; Fowler CJ; Onnis V
    Bioorg Chem; 2020 Aug; 101():104034. PubMed ID: 32599361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel propanamides as fatty acid amide hydrolase inhibitors.
    Deplano A; Morgillo CM; Demurtas M; Björklund E; Cipriano M; Svensson M; Hashemian S; Smaldone G; Pedone E; Luque FJ; Cabiddu MG; Novellino E; Fowler CJ; Catalanotti B; Onnis V
    Eur J Med Chem; 2017 Aug; 136():523-542. PubMed ID: 28535469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the N-(3-Methylpyridin-2-yl)amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode.
    Karlsson J; Morgillo CM; Deplano A; Smaldone G; Pedone E; Luque FJ; Svensson M; Novellino E; Congiu C; Onnis V; Catalanotti B; Fowler CJ
    PLoS One; 2015; 10(11):e0142711. PubMed ID: 26565710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage.
    Sasso O; Migliore M; Habrant D; Armirotti A; Albani C; Summa M; Moreno-Sanz G; Scarpelli R; Piomelli D
    FASEB J; 2015 Jun; 29(6):2616-27. PubMed ID: 25757568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Molecular Basis for Dual Fatty Acid Amide Hydrolase (FAAH)/Cyclooxygenase (COX) Inhibition.
    Palermo G; Favia AD; Convertino M; De Vivo M
    ChemMedChem; 2016 Jun; 11(12):1252-8. PubMed ID: 26593700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.
    Onnis V; Congiu C; Björklund E; Hempel F; Söderström E; Fowler CJ
    J Med Chem; 2010 Mar; 53(5):2286-98. PubMed ID: 20143779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
    Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of endocannabinoid metabolism by the metabolites of ibuprofen and flurbiprofen.
    Karlsson J; Fowler CJ
    PLoS One; 2014; 9(7):e103589. PubMed ID: 25061885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen.
    Holt S; Nilsson J; Omeir R; Tiger G; Fowler CJ
    Br J Pharmacol; 2001 Jun; 133(4):513-20. PubMed ID: 11399668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.
    Migliore M; Habrant D; Sasso O; Albani C; Bertozzi SM; Armirotti A; Piomelli D; Scarpelli R
    Eur J Med Chem; 2016 Feb; 109():216-37. PubMed ID: 26774927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation.
    Scarpelli R; Sasso O; Piomelli D
    ChemMedChem; 2016 Jun; 11(12):1242-51. PubMed ID: 26486424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.
    Wilt S; Kodani S; Valencia L; Hudson PK; Sanchez S; Quintana T; Morisseau C; Hammock BD; Kandasamy R; Pecic S
    Bioorg Med Chem; 2021 Dec; 51():116507. PubMed ID: 34794001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, spectroscopic characterization, molecular docking and theoretical studies (DFT) of N-(4-aminophenylsulfonyl)-2-(4-isobutylphenyl) propanamide having potential enzyme inhibition applications.
    Asghar A; Yousuf M; Mubeen H; Nazir R; Haruna K; Onawole AT; Rasheed L
    Bioorg Med Chem; 2019 Jun; 27(12):2397-2404. PubMed ID: 30683553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.